Bionano Genomics, Inc. (NASDAQ:BNGO) Sees Significant Growth in Short Interest

Bionano Genomics, Inc. (NASDAQ:BNGO) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 17,650,000 shares, a growth of 11.4% from the December 15th total of 15,840,000 shares. Based on an average trading volume of 6,670,000 shares, the days-to-cover ratio is currently 2.6 days. Approximately 12.7% of the company’s shares are sold short.

Bionano Genomics Stock Down 5.9 %

Shares of NASDAQ BNGO opened at $0.19 on Monday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.99 and a current ratio of 1.43. The firm has a market capitalization of $22.61 million, a price-to-earnings ratio of -0.08 and a beta of 2.22. The stock has a 50 day moving average price of $0.24 and a 200 day moving average price of $0.38. Bionano Genomics has a 52-week low of $0.18 and a 52-week high of $1.40.

Institutional Trading of Bionano Genomics

A number of hedge funds have recently bought and sold shares of BNGO. Carret Asset Management LLC boosted its position in Bionano Genomics by 89.0% during the 3rd quarter. Carret Asset Management LLC now owns 85,055 shares of the company’s stock valued at $39,000 after acquiring an additional 40,055 shares in the last quarter. GSA Capital Partners LLP bought a new stake in Bionano Genomics during the 3rd quarter valued at $46,000. Geode Capital Management LLC boosted its position in Bionano Genomics by 47.3% during the 3rd quarter. Geode Capital Management LLC now owns 882,854 shares of the company’s stock valued at $401,000 after acquiring an additional 283,639 shares in the last quarter. Finally, Armistice Capital LLC bought a new stake in Bionano Genomics during the 2nd quarter valued at $1,138,000. Hedge funds and other institutional investors own 11.35% of the company’s stock.

Analyst Ratings Changes

Separately, LADENBURG THALM/SH SH cut Bionano Genomics from a “buy” rating to a “neutral” rating in a research note on Friday, November 15th.

About Bionano Genomics

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.